Vaxxinity, Inc. (VAXX) Analyst Estimates Annual - Discounting Cash Flows
VAXX
Vaxxinity, Inc.
VAXX (OTC)
Period Ending: 2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2021
12-30
Number of Analysts 0 0 1 1 0 None
Estimated Revenue
Low 0 0 30.8 13.4 0 0.05
Average 0 0 30.8 13.4 0 0.05
High 0 0 30.8 13.4 0 0.05
Estimated EBITDA
Low 0 0 6.16 2.68 0 0.01
Average 0 0 6.16 2.68 0 0.01
High 0 0 6.16 2.68 0 0.01
Estimated EBIT
Low 0 0 6.16 2.68 0 0.01
Average 0 0 6.16 2.68 0 0.01
High 0 0 6.16 2.68 0 0.01
Estimated Net Income
Low -51.87 -51.87 -49.34 -48.07 -58.19 -198.6
Average -51.87 -51.87 -49.34 -48.07 -58.19 -198.6
High -51.87 -51.87 -49.34 -48.07 -58.19 -198.6
Estimated SGA Expenses
Low 0 0 4,991 2,171 0 8.1
Average 0 0 4,991 2,171 0 8.1
High 0 0 4,991 2,171 0 8.1
Estimated EPS
Low -0.41 -0.41 -0.39 -0.38 -0.46 -1.57
Average -0.41 -0.41 -0.39 -0.38 -0.46 -1.57
High -0.41 -0.41 -0.39 -0.38 -0.46 -1.57
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program